2021
DOI: 10.1016/j.ymthe.2021.04.020
|View full text |Cite
|
Sign up to set email alerts
|

Extracellular vesicles in neuroinflammation: Pathogenesis, diagnosis, and therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
34
0
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 49 publications
(36 citation statements)
references
References 130 publications
0
34
0
2
Order By: Relevance
“…At present, the pathogenesis of inflammatory diseases of the central nervous system [including neurodegenerative diseases ( Ruan et al, 2021 ; Xiao et al, 2021 )] and autoimmune diseases ( Xu et al, 2022 ) has not been completely clarified, but more and more studies have begun to focus on the role of EVs in autoimmune diseases and research on treatment of EVs ( Guo et al, 2019 ; Chu et al, 2020 ; Dar et al, 2021 ; Saeedi et al, 2021 ; Xia et al, 2021 ). Studies have found that multiple miRNAs are involved in neuroinflammation and neurological diseases, such as Parkinson’s disease ( Xie et al, 2020c ), Alzheimer’s disease (AD) ( Dong et al, 2021 ), amyotrophic lateral sclerosis ( Liu et al, 2022 ), and depression ( Trotta et al, 2018 ; Chen and Wang, 2021 ).…”
Section: Diagnostic Value Of Extracellular Vesicle-derived Microrna I...mentioning
confidence: 99%
“…At present, the pathogenesis of inflammatory diseases of the central nervous system [including neurodegenerative diseases ( Ruan et al, 2021 ; Xiao et al, 2021 )] and autoimmune diseases ( Xu et al, 2022 ) has not been completely clarified, but more and more studies have begun to focus on the role of EVs in autoimmune diseases and research on treatment of EVs ( Guo et al, 2019 ; Chu et al, 2020 ; Dar et al, 2021 ; Saeedi et al, 2021 ; Xia et al, 2021 ). Studies have found that multiple miRNAs are involved in neuroinflammation and neurological diseases, such as Parkinson’s disease ( Xie et al, 2020c ), Alzheimer’s disease (AD) ( Dong et al, 2021 ), amyotrophic lateral sclerosis ( Liu et al, 2022 ), and depression ( Trotta et al, 2018 ; Chen and Wang, 2021 ).…”
Section: Diagnostic Value Of Extracellular Vesicle-derived Microrna I...mentioning
confidence: 99%
“…The ability to exchange information and to deliver bioactive substances to target cells gives EVs great potential for treating human disease [135]. EVs can be transferred to target organs, and thus are widely considered as natural nanocarriers, which show great prospect for application as drug targeting vectors [136][137][138][139][140][141][142]. These researches opened a new area in OS research, linking emerging nanocarrier EVs to the progression, prognosis, and treatment of OS.…”
Section: Evs In the Treatment Of Osteosarcomamentioning
confidence: 99%
“…Many studies have shown that EVs exert vital effects on biological and pathological processes in the central nervous system (CNS), including neuronal differentiation, synaptic formation, glial crosstalk, and regulation of homeostatic signaling and the immune system ( 17 19 ). Moreover, it is well known that EVs are key mediators of CNS neuroimmune interactions and serve as essential regulators of neuroinflammation following TBI by carrying various kinds of cargo, such as DNA fragments, RNA, lipids, and proteins ( 20 , 21 ). In this review, we summarize the pro-inflammatory function of EVs and the overall effect of diverse cell type-derived EVs on TBI-associated neuroinflammation.…”
Section: Introductionmentioning
confidence: 99%